Canopy Growth (TSE:WEED) Third Quarter 2025 Results
Key Financial Results
- Revenue: CA$74.8m (down 4.8% from 3Q 2024).
- Net loss: CA$121.9m (loss narrowed by 47% from 3Q 2024).
- CA$1.11 loss per share (improved from CA$2.78 loss in 3Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Canopy Growth Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 8.1%. Earnings per share (EPS) missed analyst estimates by 95%.
Looking ahead, revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Pharmaceuticals industry in Canada.
Performance of the Canadian Pharmaceuticals industry.
The company’s share price is broadly unchanged from a week ago.
Risk Analysis
Before you take the next step you should know about the 2 warning signs for Canopy Growth (1 makes…
